Stress-induced interleukin-6 release in mice is mast cell-dependent and more pronounced in Apolipoprotein E knockout mice

Cardiovascular Research

Volumn 59, Issue 1, 2003, Pages 241-249

  Huang, Man ^a   Pang, Xinzhu ^a   Karalis, Katia ^b   Theoharides, Theoharis C ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Atherosclerosis; Coronary disease; Cytokines; Inflammation; Stress

Indexed keywords

APOLIPOPROTEIN E; ASTRESSIN; CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CROMOGLYCATE DISODIUM; INTERLEUKIN 6; NEUROCRINE; UROCORTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CELL ACTIVATION; CELL FUNCTION; CELL LOSS; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CYTOKINE RELEASE; HORMONE DEFICIENCY; HORMONE DETERMINATION; IMMOBILIZATION STRESS; KNOCKOUT MOUSE; MAST CELL; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; QUANTITATIVE ANALYSIS; STRESS; WILD TYPE;

ANIMALS; APOLIPOPROTEINS E; CORONARY DISEASE; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; CROMOLYN SODIUM; INTERLEUKIN-6; MAST CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PEPTIDE FRAGMENTS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; STRESS;

EID: 0038094519     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(03)00340-7     Document Type: Article

References (56)

1. Chrousos G.P. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. New Engl J Med. 332:1995;1351-1362.
2. Deedwania P.C. Mental stress, pain perception and risk of silent ischemia. J Am Coll Cardiol. 25:1995;1504-1506.
3. Freeman L.J., Nixon P.G.F., Sallabank P., Reaveley D. Psychological stress and silent myocardial ischemia. Am Heart J. 114:1987;477-482.
4. Deanfield J.E., Shea M., Kensett M., et al. Silent myocardial ischaemia due to mental stress. Lancet. 2:1984;1001-1005.
5. Rozanski A., Bairey C.N., Krantz D.S., et al. Mental stress and the induction of silent myocardial ischemia in patients with coronary artery disease. New Engl J Med. 318:1988;1005-1012.
6. Jiang W., Babyak M., Krantz D.S., et al. Mental stress-induced myocardial ischemia and cardiac events. J. Am. Med. Assoc. 275:1996;1651-1656.
7. Karalis K., Louis J.M., Bae D., Hilderbrand H., Majzoub J.A. CRH and the immune system. J Neuroimmunol. 72:1997;131-136.
8. Vaughan J., Donaldson C., Bittencourt J., et al. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature. 378:1995;287-292.
9. Bamberger C.M., Wald M., Bamberger A.-M., et al. Human lymphocytes produce urocortin, but not corticotropin-releasing hormone. J Clin Endocrinol Metab. 83:1998;708-711.
10. Schoder H., Silverman D.H., Campisi R., et al. Effect of mental stress on myocardial blood flow and vasomotion in patients with coronary artery disease. J Nucl Med. 41:2000;11-16.
11. Papanicolaou D., Wilder R.L., Manolagas S.C., Chrousos G. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med. 128:1998;127-137.
12. Deliargyris E.N., Raymond R.J., Theoharides T.C., et al. Sites of interleukin-6 release in patients with acute coronary syndromes and in patients with congestive heart failure. Am J Cardiol. 86:2000;913-918.
13. Herity N.A. Interleukin 6: a message from the heart. Heart. 84:2000;9-10.
14. Ando T., Rivier J., Yanaihara H., Arimura A. Peripheral corticotropin-releasing factor mediates the elevation of plasma IL-6 by immobilization stress in rats. Am J Physiol. 275:1998;R1461-R1467.
15. Nukina H., Sudo N., Aiba Y., et al. Restraint stress elevates the plasma interleukin-6 levels in germ-free mice. J Neuroimmunol. 115:2001;46-52.
16. Caligiuri G., Levy B., Pernow J., Thoren P., Hansson G.K. Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice. Proc Natl Acad Sci USA. 96:1999;6920-6924.
17. Baraille R., Klein B. C-reactive protein levels as a direct indicator of interleukin-6 levels in humans in vivo. Arthritis Rheum. 35:1992;982-984.
18. Harris T.B., Ferrucci L., Tracy R.P., et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med. 106:1999;506-512.
19. Yudkin J.S., Kumari M., Humphries S.E., Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis. 148:2000;209-214.
20. Rozniecki J.J., Prusinski A. Oral sodium cromoglycate in the treatment of food migraine - a pilot study. Cephalalgia. 11:1991;146-147.
21. Theoharides T.C. The mast cell: a neuroimmunoendocrine master player. Int J Tissue React. 18:1996;1-21.
22. Krüger-Krasagakes S., Möller A.M., Kolde G., et al. Production of interleukin-6 by human mast cells and basophilic cells. J Invest Dermatol. 106:1996;75-79.
23. Constantinides P. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation. 92:1995;1083-1088.
24. Kaartinen M., Penttilä A., Kovanen P.T. Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. Circulation. 90:1994;1669-1678.
25. Laine P., Kaartinen M., Penttilä A., et al. Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery. Circulation. 99:1999;361-369.
26. Pang X., Alexacos N., Letourneau R., et al. A neurotensin receptor antagonist inhibits acute immobilization stress-induced cardiac mast cell degranulation, a corticotropin-releasing hormone-dependent process. J Pharm Exp Ther. 287:1998;307-314.
27. Huang M., Pang X., Letourneau L., Boucher W., Theoharides T.C. Acute stress induces cardiac mast cell activation and histamine release, effects that are increased in apolipoprotein E knockout mice. Cardiovasc Res. 55:2002;150-160.
28. Chester A.H. Mast cells feel the strain. Cardiovasc Res. 55:2002;13-15.
29. Weninger S.C., Dunn A.J., Muglia L.J., et al. Stress-induced behaviors require the corticotropin-releasing hormone (CRH) receptor, but not CRH. Proc Natl Acad Sci USA. 96:1999;8283-8288.
30. Zhang S.H., Reddick R.L., Piedrahita J.A., Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 258:1992;468-471.
31. Sukovich D.A., Kauser K., Shirley F.D., et al. Expression of interleukin-6 atherosclerotic lesions of male ApoE-knockout mice. Arterioscler Thromb. 18:1998;1498-1505.
32. Huber S.A., Sakkinen P., Conze D., Hardin N., Tracy R. Interleukin-6 exacerbates early atherosclerosis in mice. Arterioscler Thromb. 19:1999;2364-2367.
33. Alexander R.W. Inflammation and coronary artery disease. New Engl J Med. 31:1994;468-469.
34. Maseri A. Inflammation, atherosclerosis and ischemic events - exploring the hidden side of the moon. New Engl J Med. 336:1997;1014-1016.
35. Woods A., Brull D.J., Humphries S.E., Montgomery H.E. Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6. Eur Heart J. 21:2000;1574-1583.
36. Secor V.H., Secor W.E., Gutekunst C.-A., Brown M.A. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J Exp Med. 191:2000;813-821.
37. Kovanen P.T. The mast cell - potential link between inflammation and cellular cholesterol deposition in atherogenesis. Eur Heart J. 14:1993;105-117.
38. Galli S.J. New concepts about the mast cell. New Engl J Med. 328:1993;257-265.
39. Klein L.M., Lavker R.M., Matis W.L., Murphy G.F. Degranulation of human mast cells induces an endothelial antigen central to leukocyte adhesion. Proc Natl Acad Sci USA. 86:1989;8972-8976.
40. Laine P., Naukkarinen A., Heikkila L., Penttilä A., Kovanen P.T. Adventitial mast cells connect with sensory nerve fibers in atherosclerotic coronary arteries. Circulation. 101:2000;1665-1669.
41. Gurish M.F., Austen K.F. The diverse roles of mast cells. J Exp Med. 194:2001;1-6.
42. Gagari E., Tsai M., Lantz C.S., Fox L.G., Galli S.J. Differential release of mast cell interleukin-6 via c-kit. Blood. 89:1997;2654-2663.
43. Kukielka G.L., Smith C.W., Manning A.M., et al. Induction of interleukin-6 synthesis in the myocardium. Circulation. 92:1995;1866-1875.
44. Gwechenberger M., Mendoza L.H., Youker K.A., et al. Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions. Circulation. 99:1999;546-551.
45. Theoharides T.C., Singh L.K., Boucher W., et al. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its pro-inflammatory effects. Endocrinology. 139:1998;403-413.
46. Singh L.K., Boucher W., Pang X., et al. Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of CRH receptors. J Pharmacol Exp Ther. 288:1999;1349-1356.
47. Martinez V., Rivier J., Wang L., Tache Y. Central injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks CRF- and stress-related alterations of gastric and colonic motor function. J Pharm Exp Ther. 280:1997;754-760.
48. Stenzel P., Kesterson R., Yeung W., et al. Identification of a novel murine receptor for corticotropin-releasing hormone expressed in the heart. Mol Endocrinol. 9:1995;637-645.
49. Nishikimi T., Miyata A., Horio T., et al. Urocortin, a member of the corticotropin-releasing factor family, in normal and diseased heart. Am J Physiol Heart Circ Physiol. 279:2000;H3031-H3039.
50. Zhou D., Kusnecov A.W., Shurin M.R., DePaoli M. Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic-pituitary-adrenal axis. Endocrinology. 133:1993;2523-2530.
51. Jacobson L., Muglia L.J., Weninger S.C., Pacak K., Majzoub J.A. CRH deficiency impairs but does not block pituitary-adrenal responses to diverse stressors. Neuroendocrinology. 71:2000;79-87.
52. Bethin K.E., Vogt S.K., Muglia L.J. Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation. Proc Natl Acad Sci USA. 97:2000;9317-9322.
53. Yamauchi-Takihara K., Ihara Y., Ogata A., et al. Hypoxic stress induces cardiac myocyte-derived interleukin-6. Circulation. 91:1995;1520-1524.
54. Huang M., Basu S., Pang X., et al. Stress-induced interleukin-6 release in mice is mast cell-dependent and also involves cardiomyocytes stimulated by urocortin. FASEB J. 16:2002;A182.
55. Gottdiener J.S., Krantz D.S., Howell R.H., et al. Induction of silent myocardial ischemia with mental stress testing: relation to triggers of ischemia during daily life activities and to ischemic functional severity. J Am Coll Cardiol. 24:1994;1645-1651.
56. Specchia G., Falcone C., Traversi E., et al. Mental stress as a provocative test in patients with various clinical syndromes of coronary heart disease. Circulation. 83:1991;II108-II114.